Prevalence of metabolic syndrome and its individual components among diabetic patients in Ghana

Journal of Biological Sciences

Volumn 8, Issue 6, 2008, Pages 1057-1061

  Titty, Felix Val K ^b   Owiredu, W K B A ^a   Agyei Frempong, Margaret T ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b University for Developmental Studies   (Ghana)

Author keywords

Cardiovascular risk factors; Diabetes mellitus; Dyslipidaemia; Hypertension; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; FEMALE; GHANA; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PROSPECTIVE STUDY; SEX DIFFERENCE;

EID: 60249087065     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2008.1057.1061     Document Type: Article

References (19)

1. Al-Lawati, J.A., A.J. Mohammed, H.Q. Al-Hinai and P. Jousilahti, 2003. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care, 26: 1781-1785.
2. Alberti, K.G. and P.Z. Zimmet, 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet. Med., 15: 539-553.
3. Eriksson, K.F. and F. Lindgarde, 1991. The prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia, 34: 891-898.
4. Ford, E. S., W.H. Giles and W.H. Dietz, 2002. Prevalence of the metabolic syndrome among US adults: Findings ftom the 3rd national health and nutrition examination survey. J. Am. Med. Assoc., 287: 356-359.
5. Gordon, D.J., J.L. Probstfield, R.J. Garrison, J.D. Neaton and W.P. Castelli et al., 1989. High density lipoprotein, cholesterol and cardiovascular disease: Four prospective American studiens. Circulation, 79: 8-15.
6. Groop, L., A. Ekstrand, C. Forsblom, E. Widén, P.H. Groop, A.M. Teppo and J. Eriksson, 1993. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 36: 642-647.
7. Isomaa, B., P. Almgren, T. Tuomi, B. Forsén and K. Lahti et al., 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24: 683-689.
8. Kaplan, N.M., 1982. The deadly quartet: Upper body adiposity, glucose intolerance, hypertriglyceridaemia and hypertension. Arch. Int. Med., 149: 1514-1520.
9. Laaksonen, D.E., L. Niskanen, K. Nyyssonen, K. Punnonen and T.P. Tuomainen et al., 2004. C-reactive protein and the development of metabolic syndrome and diabetes in middle-aged men. Diabetologia, 47: 1403-1410.
10. Lakka, H.M., D.E. Laaksonen, T.A. Lakka, L.K. Niskanen and E. Kumpusalo et al., 2002. The Metabolic syndrome and total cardiovascular disease mortality in middle-aged men. J. Am. Med. Aassoc., 288: 2709-2716.
11. Loizou, T., S. Pouloukas, C. Tountas, A. Thanopoulou and V. Karamanos, 2006. An epidemiologic study on the prevalence of diabetes, glucose intolerance and metabolic syndrome in the adult population of the Republic of Cyprus. Diabetes Care, 29: 1714-1715.
12. Marchesini, G., G. Forlani, F. Cerrelli, R. Manini and S. Natale et al., 2004. WHO and ATPIII proposals for the definition of metabolic syndrome in patients with type 2 diabetes. Diabet. Med., 21: 383-387.
13. NCEP ATPIII, 2001. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults: Executive summary on the 3rd report of the national cholesterol education programme. (Adult Treatment Panel III). J. Am. Med. Assoc., 285: 2486-2497.
14. Park, Y.W., S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon and S.B. Heymsfield, 2003. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the 3rd national health and nutrition examination survey, 1988-1994. Arch. Int. Med., 163: 427-436.
15. Scuteri, A., S.S. Najjar, C.H. Morrell and E.G. Lakatta, 2005. Metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: The cardiovascular health study. Diabetes Care, 28: 882-887.
16. Steinberg, H.O., H. Chaker, R. Learning, A. Johnson, G. Brechtel and A.D. Baron, 1996. Obesity/insulin resistance is associated with endothelial dysfunction: Implications for the syndrome of insulin resistance. J. Clin. Invest., 97: 2601-2610.
17. Thorn, L.M., C. Forsblom, J. Fagerudd, M.C. Thomas and K. Pettersson-Fernholm et al., 2005. Metabolic syndrome in type 1 diabetes: Association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care, 28: 2019-2024.
18. Trevisan, M., J. Liu, F.B. Bahsas, A. Menotti and the Risk Factor and Life Expectancy Research Group, 1998. Syndrome X and mortality: A Population-based study. Am. J. Epidermol., 148: 958-966.
19. Yudkin, J.S., 1999. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?. Diabetes Care, 22: C25-C30.